Legis Daily

Right to Test Act

USA117th CongressHR-719| House 
| Updated: 2/3/2021
Patrick T. McHenry

Patrick T. McHenry

Republican Representative

North Carolina

Cosponsors (2)
Chip Roy (Republican)James Comer (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Right to Test Act This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency. Unless requested by the governor of the state, the Food and Drug Administration (FDA) must not, during the emergency, engage in certain enforcement actions related to such a test or device. Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-7017
Right to Test Act
Feb 2, 2021

Latest Companion Bill Action

S 117-152
Introduced in Senate
Feb 2, 2021
Introduced in House
Feb 2, 2021
Referred to the House Committee on Energy and Commerce.
Feb 3, 2021
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-7017
    Right to Test Act


  • February 2, 2021

    Latest Companion Bill Action

    S 117-152
    Introduced in Senate


  • February 2, 2021
    Introduced in House


  • February 2, 2021
    Referred to the House Committee on Energy and Commerce.


  • February 3, 2021
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 117-152: Right to Test Act
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careHealth technology, devices, suppliesInfectious and parasitic diseasesMedical tests and diagnostic methodsState and local government operations

Right to Test Act

USA117th CongressHR-719| House 
| Updated: 2/3/2021
Right to Test Act This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency. Unless requested by the governor of the state, the Food and Drug Administration (FDA) must not, during the emergency, engage in certain enforcement actions related to such a test or device. Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-7017
Right to Test Act
Feb 2, 2021

Latest Companion Bill Action

S 117-152
Introduced in Senate
Feb 2, 2021
Introduced in House
Feb 2, 2021
Referred to the House Committee on Energy and Commerce.
Feb 3, 2021
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-7017
    Right to Test Act


  • February 2, 2021

    Latest Companion Bill Action

    S 117-152
    Introduced in Senate


  • February 2, 2021
    Introduced in House


  • February 2, 2021
    Referred to the House Committee on Energy and Commerce.


  • February 3, 2021
    Referred to the Subcommittee on Health.
Patrick T. McHenry

Patrick T. McHenry

Republican Representative

North Carolina

Cosponsors (2)
Chip Roy (Republican)James Comer (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 117-152: Right to Test Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careHealth technology, devices, suppliesInfectious and parasitic diseasesMedical tests and diagnostic methodsState and local government operations